Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models
Compose a Response to This Article
Other responses
No responses have been published for this article.
